Cannabis Use with Medical Abortion
There is no evidence that cannabis is unsafe to use before or after taking abortion pills (mifepristone and misoprostol), though it does not appear to provide meaningful benefit for pain control.
Key Evidence on Cannabis and Medical Abortion
The available research specifically examining cannabis use during medication abortion shows:
No safety concerns identified: A prospective cohort study found no significant adverse events or complications associated with marijuana use during medication abortion 1
No proven pain benefit: A randomized controlled trial of dronabinol (synthetic THC) showed no reduction in maximum pain scores compared to placebo (both groups reported median pain of 7/10) 2
Similar satisfaction rates: Women who used marijuana had comparable satisfaction scores to non-users (22 vs. 20 out of 30, p=0.90), though many marijuana users subjectively attributed symptom improvement to cannabis 1
Pain scores unchanged: Objective pain measurements over 24 hours after misoprostol showed no difference between marijuana users and non-users 1
Clinical Implications
You can counsel patients that:
- Cannabis use does not appear to interfere with the effectiveness or safety of mifepristone and misoprostol
- Cannabis has not been proven to reduce pain during medical abortion in controlled studies
- If patients choose to use cannabis, they should still take recommended pain medications (ibuprofen 800mg) as these have established efficacy 3
- Some patients report subjective benefit for anxiety, nausea, or pain, though this was not confirmed in objective measurements 1
Important Caveats
The current guidelines for medication abortion 3 do not address cannabis use, as it is not part of standard pain management protocols. The Society of Family Planning recommends a stepwise multimodal approach to pain management 3, which typically includes NSAIDs as first-line therapy.
The absence of documented harm does not constitute a recommendation for use - cannabis simply has not been studied extensively enough in this context to make definitive claims about efficacy. The existing studies were small and observational or involved synthetic cannabinoids rather than whole-plant cannabis.
Patients should be informed that proven pain management strategies (NSAIDs, opioids if needed) remain the evidence-based standard 3.